Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketofol vs Etomidate for Intubation in Critically Ill
NCT02105415Phase 3Completed
- Sponsor
- Mayo Clinic
- Start
- Apr 2014
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ketamine and propofol in critical illness (2 arms), sponsored by Mayo Clinic. Primary endpoint: Mean Arterial Pressure. Started Apr 2014; status: completed.
02
Drugs
ketaminepropofol
03
Conditions
critical illness
Beyond the preview
Go deeper on NCT02105415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02105415.